UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association Studies Suggest a Key Role for Endothelin-1 in the Pathogenesis of Preeclampsia and the Accompanying Renin–Angiotensin–Aldosterone System Suppression

Hypertension (Dallas, Tex. 1979), 2015-06, Vol.65 (6), p.1316-1323

2015

Volltextzugriff (PDF)

The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia

Therapeutic Advances in Cardiovascular Disease, 2016-10, Vol.10 (5), p.282-293

2016

Volltextzugriff (PDF)

Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment

Current opinion in nephrology and hypertension, 2016-03, Vol.25 (2), p.94-99

2016

Volltextzugriff (PDF)

Tumor Necrosis Factor Inhibitor Use Increases Birthweight in Pregnant Women With Rheumatoid Arthritis Independently of the Soluble Fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio

Journal of the American Heart Association, 2024-04, Vol.13 (7), p.e032655-e032655

2024

Volltextzugriff (PDF)

PAPP-A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia

Journal of the American Heart Association, 2020-10, Vol.9 (19), p.e018219

2020

Volltextzugriff (PDF)

Endothelin receptor antagonism during preeclampsia: a matter of timing?

Clinical science (1979), 2019-06, Vol.133 (12), p.1341-1352

2019

Volltextzugriff (PDF)

GLYCOSYLATED FIBRONECTIN AS A NOVEL PREDICTOR FOR THE MATERNAL AND FETAL COMPLICATIONS OF PREECLAMPSIA

Journal of hypertension, 2024-05, Vol.42 (Suppl 1), p.e56

2024

Volltextzugriff (PDF)

Glycosylated fibronectin as a novel predictor for the maternal and fetal complications of preeclampsia

Placenta (Eastbourne), 2024-09, Vol.154, p.e7

2024

Volltextzugriff (PDF)

TNF ALPHA INHIBITOR USE AFFECTS BIRTHWEIGHT INDEPENDENTLY OF THE SOLUBLE FMS-LIKE TYROSINE KINASE 1 / PLACENTAL GROWTH FACTOR RATIO IN PREGNANT WOMEN WITH RHEUMATOID

Journal of hypertension, 2023-06, Vol.41 (Suppl 3), p.e65-e66

2023

Volltextzugriff (PDF)

The impact of implementing the WHO-2013 criteria for gestational diabetes mellitus on its prevalence and pregnancy outcomes: A comparison of the WHO-1999 and WHO-2013 diagnostic thresholds

European journal of obstetrics & gynecology and reproductive biology, 2020-03, Vol.246, p.14-18

2020

Volltextzugriff (PDF)

Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors

Hypertension (Dallas, Tex. 1979), 2017-09, Vol.70 (3), p.594-600

2017

Volltextzugriff (PDF)

The impact of implementing the WHO-2013 criteria for gestational diabetes mellitus on its prevalence and pregnancy outcomes: A comparison of the WHO-1999 and WHO-2013 diagnostic thresholds

European journal of obstetrics & gynecology and reproductive biology, 2020-06, Vol.249, p.107-107

2020

Volltextzugriff (PDF)

Omeprazole Administration in Preterm Preeclampsia: a Randomized Controlled Trial to Study Its Effect on sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1), PlGF (Placental Growth Factor), and ET-1 (Endothelin-1)

Hypertension (Dallas, Tex. 1979), 2022-06, Vol.79 (6), p.1297-1307

2022

Volltextzugriff (PDF)

416. The impact of implementing the new diagnostic criteria of gestational diabetes mellitus on prevalence and pregnancy outcomes

Pregnancy hypertension, 2018-10, Vol.13, p.S149-S149

2018

Volltextzugriff (PDF)

Abstract 040: Low Soluble Fms-like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors

Hypertension (Dallas, Tex. 1979), 2017-09, Vol.70 (suppl_1)

2017

Volltextzugriff (PDF)

Angiogenic Markers Predict Pregnancy Complications and Prolongation in Preeclampsia: Continuous Versus Cutoff Values

Hypertension (Dallas, Tex. 1979), 2017-11, Vol.70 (5), p.1025-1033

2017

Volltextzugriff (PDF)

Abstract 147: Copeptin and Mid-Regional Pro-ANP in Women With Suspected or Confirmed Preeclampsia: Comparison With the sFlt-1/PlGF Ratio

Hypertension (Dallas, Tex. 1979), 2019-09, Vol.74 (Suppl_1)

2019

Volltextzugriff (PDF)

Etiology of angiogenesis inhibition-related hypertension

Current opinion in pharmacology, 2015-04, Vol.21, p.7-13

2015

Volltextzugriff (PDF)

Effect of oral protein hydrolysate on glucose control in patients with gestational diabetes

Clinical nutrition (Edinburgh, Scotland), 2018-06, Vol.37 (3), p.878-883

2018

Volltextzugriff (PDF)

Abstract P093: The Sflt-1/plgf Ratio Associates with Prolongation of Pregnancy

Hypertension (Dallas, Tex. 1979), 2015-09, Vol.66 (suppl_1)

2015

Volltextzugriff (PDF)

The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies

Pregnancy hypertension, 2018-10, Vol.14, p.222-227

2018

Volltextzugriff (PDF)

Y-008. Accurate prediction of total PlGF from free PlGF and sFlt-1: Evidence for markedly elevated PlGF levels in acute fatty liver of pregnancy

Pregnancy hypertension, 2021-09, Vol.25, p.e19-e20

2021

Volltextzugriff (PDF)

Do prorenin-synthesizing cells release active, ‘open’ prorenin?

Journal of hypertension, 2017-02, Vol.35 (2), p.330-337

2017

Volltextzugriff (PDF)

247. Effect of aspirin on soluble Fms-like tyrosine kinase-1 levels and placental growth factor in women with suspected or confirmed preeclampsia

Pregnancy hypertension, 2018-10, Vol.13, p.S34-S35

2018

Volltextzugriff (PDF)

246. Baseline characteristics and angiogenic markers in women diagnosed with preeclampsia according to the new ISSHP and ACOG criteria

Pregnancy hypertension, 2018-10, Vol.13, p.S109-S109

2018

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Association Studies Suggest a Key Role for Endothelin-1 in the Pathogenesis of Preeclampsia and the Accompanying Renin–Angiotensin–Aldosterone System Suppression

The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia

Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment

Tumor Necrosis Factor Inhibitor Use Increases Birthweight in Pregnant Women With Rheumatoid Arthritis Independently of the Soluble Fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio

PAPP-A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia

Endothelin receptor antagonism during preeclampsia: a matter of timing?

GLYCOSYLATED FIBRONECTIN AS A NOVEL PREDICTOR FOR THE MATERNAL AND FETAL COMPLICATIONS OF PREECLAMPSIA

Glycosylated fibronectin as a novel predictor for the maternal and fetal complications of preeclampsia

TNF ALPHA INHIBITOR USE AFFECTS BIRTHWEIGHT INDEPENDENTLY OF THE SOLUBLE FMS-LIKE TYROSINE KINASE 1 / PLACENTAL GROWTH FACTOR RATIO IN PREGNANT WOMEN WITH RHEUMATOID

The impact of implementing the WHO-2013 criteria for gestational diabetes mellitus on its prevalence and pregnancy outcomes: A comparison of the WHO-1999 and WHO-2013 diagnostic thresholds

Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors

The impact of implementing the WHO-2013 criteria for gestational diabetes mellitus on its prevalence and pregnancy outcomes: A comparison of the WHO-1999 and WHO-2013 diagnostic thresholds

Omeprazole Administration in Preterm Preeclampsia: a Randomized Controlled Trial to Study Its Effect on sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1), PlGF (Placental Growth Factor), and ET-1 (Endothelin-1)

416. The impact of implementing the new diagnostic criteria of gestational diabetes mellitus on prevalence and pregnancy outcomes

Abstract 040: Low Soluble Fms-like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors

Angiogenic Markers Predict Pregnancy Complications and Prolongation in Preeclampsia: Continuous Versus Cutoff Values

Abstract 147: Copeptin and Mid-Regional Pro-ANP in Women With Suspected or Confirmed Preeclampsia: Comparison With the sFlt-1/PlGF Ratio

Etiology of angiogenesis inhibition-related hypertension

Effect of oral protein hydrolysate on glucose control in patients with gestational diabetes

Abstract P093: The Sflt-1/plgf Ratio Associates with Prolongation of Pregnancy

The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies

Y-008. Accurate prediction of total PlGF from free PlGF and sFlt-1: Evidence for markedly elevated PlGF levels in acute fatty liver of pregnancy

Do prorenin-synthesizing cells release active, ‘open’ prorenin?

247. Effect of aspirin on soluble Fms-like tyrosine kinase-1 levels and placental growth factor in women with suspected or confirmed preeclampsia

246. Baseline characteristics and angiogenic markers in women diagnosed with preeclampsia according to the new ISSHP and ACOG criteria

Suchergebnisse filtern